For the Inventor, By the Inventor

Enter assignee name

Austin, TX, United States of America

Asuragen, Inc.

USPTO Granted Patents = 31

CIPO Patents = 2

EPO Patents = 35

Trademarks = 9

Forward Citations = 457

Loading Chart...

Loading Chart...

35 inventors (with patents filed for the assignee):

David Allen Brown (19 out of 73 patents)

Eric Devroe (13 out of 14 patents)

Kevin Kelnar (12 out of 20 patents)

4. Mike Byrom (10 out of 19 patents)

5. Dmitriy Ovcharenko (10 out of 17 patents)

6. Lance Ford (10 out of 14 patents)

7. Angie Cheng (10 out of 12 patents)

8. Rich Jarvis (10 out of 11 patents)

9. Gary J Latham (9 out of 17 patents)

10. Emmanuel Labourier (8 out of 8 patents)

11. Jeffrey Shelton (8 out of 10 patents)

12. Kerri Keiger (6 out of 6 patents)

13. Jaclyn Shingara (6 out of 6 patents)

14. Liangjing Chen (5 out of 8 patents)

15. Sachin Sah (5 out of 5 patents)

31 patents: Sort by Forward Citations

1. 12139755 - Methods of RNA amplification (2024-11-12),

2. 11913068 - Methods for nucleic acid size detection of repeat sequences (2024-02-27),

3. 11236384 - Methods of RNA amplification (2022-02-01),

4. 11214829 - Methods, compositions, kits, and uses for analysis of nucleic acids comprising repeating A/T-rich segments (2022-01-04),

5. 10047388 - Methods and compositions involving MicroRNA (2018-08-14),

6. 9783848 - PCR methods for characterizing the 5' untranslated region of the FMR1 and FMR2 genes (2017-10-10),

7. 9777330 - mPCR methods for analyzing repeat sequences (2017-10-03),

8. 9540645 - Compositions and methods related to miRNA modulation of neovascularization or angiogenesis (2017-01-10),

9. 9506061 - Methods and compositions involving miRNA and miRNA inhibitor molecules (2016-11-29),

10. 9447414 - Methods and compositions involving miRNA and miRNA inhibitor molecules (2016-09-20),

11. 9382537 - Methods and compositions involving miRNA and miRNA inhibitor molecules (2016-07-05),

12. 9371560 - Comprehensive FMR1 genotyping (2016-06-21),

13. 9080215 - MicroRNAs differentially expressed in cervical cancer and uses thereof (2015-07-14),

14. 9068219 - Methods and compositions involving miRNA and miRNA inhibitor molecules (2015-06-30),

15. 9051571 - Methods and compositions involving miRNA and miRNA inhibitor molecules (2015-06-09),

Asuragen, Inc. is a molecular diagnostics company that develops and commercializes diagnostic products to help patients with genetic diseases and cancer. They specialize in RNA-based diagnostics including quantitative PCR and next-generation sequencing. Asuragen's innovative solutions enable healthcare providers to make informed decisions about patient care. For more information, visit their official website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

31 Patents

#98 in Austin, TX

#598 in Texas

#10,560 in US

#20,637 in the World

Austin, TX, United States of America

Asuragen, Inc.

Forward Citations = 457

35 inventors:

David Allen Brown (19 out of 73 patents)

Eric Devroe (13 out of 14 patents)

Kevin Kelnar (12 out of 20 patents)

4. Mike Byrom (10 out of 19 patents)

5. Dmitriy Ovcharenko (10 out of 17 patents)

Please report any incorrect information to support@idiyas.com

Loading…